Ferriprive anemia in patients with erythropoietic protoporphyria

Completed

• Conditions: cutaneous porphyria; EPP; 10027424; 10021605; 10014982

• Registration Number: NL-OMON31219
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

- Known diagnosis of erythropoietic protoporphyria
- age = 18 years or older

Exclusion Criteria

none

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary study variables are:<br /><br><br /><br>- The amount of protoporphyrin, the activity of the enzyme ferrochelatase,<br /><br>the liver functions and the score of the quality of life<br /><br>questionnaire show<br /><br>the gravity of the symptoms of EPP<br /><br>- The presence or not of a low amount of hemoglobin<br /><br>- The presence or not of iron deficiency</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n.a.</p><br>